Education

Education

Patient-focused resources, tips from experts, and challenging clinical questions from ASH Clinical News

You Make the Call

You Make the Call: Is warfarin recommended for a patient with recurrent coronary artery closure?

This month, Michael Kroll, MD, discusses management of a patient with recurrent coronary artery closure. And don’t forget to check out next month’s clinical dilemma – send in...
How I Treat In Brief

How I Treat in Brief: Anticoagulation in Patients With Obesity

This month, Tzu-Fei Wang, MD, and Marc Carrier, MD, MSc, reviewed anticoagulation strategies for patients who are obese and therefore at risk of venous thromboembolism, atrial...
You Make the Call

You Make the Call: Should this patient with DLBCL receive rituximab maintenance after R-CHOP?

This month Ann S. LaCasce, MD, MMSc, discusses whether a patient with high-risk DLBCL should receive rituximab maintenance after R-CHOP (rituximab, cyclophosphamide, doxorubicin hydrochloride,...

How I Teach Professionalism With Ariela Marshall, MD

Ariela Marshall, MD, talks about modeling professional communication for trainees by respecting patients’ and colleagues’ differences in gender identity, culture, ethnicity, sexual orientation, and...
You Make the Call

You Make the Call: How would you treat these patients with acute stroke who...

This month Keith R. McCrae, MD, discusses anticoagulation for patients with antiphospholipid antibodies and a history of stroke. And don't forget to check out next month's...

Demystifying PCR-Based Molecular Monitoring in CML

When imatinib, the first tyrosine kinase inhibitor (TKI), was approved for the treatment of chronic myeloid leukemia (CML) in 2001, the disease’s natural history...
You Make the Call

You Make the Call: Would rituximab re-treatment help this patient with hemolytic anemia?

This month, Edward Benz Jr., MD, discusses treatment of Coombs-positive hemolytic anemia in a patient who declines to undergo splenectomy.I am caring for a...
You Make the Call

You Make the Call: How would you treat a frail patient with relapsed hairy cell...

This month, Marty Tallman, MD, discusses treatment of early-relapsing hairy cell leukemia variant. And don't forget to check out next month's clinical dilemma - send...

Maintenance of Certification: An Update on ABIM’s Evolving Requirements

Three decades ago, the American Board of Internal Medicine (ABIM) announced the end of the “board-certified-for-life” status that had been in place since the...
You Make the Call

You Make the Call: What is the best consolidation therapy for this patient with...

This month, Erin Reid, MD, discusses treatment of primary central nervous system lymphoma. And don't forget to check out next month's clinical dilemma - send...
Advertisement

Current Issue

August 2020 Volume 6, Issue 10

This issue looks at the rapid expansion of telemedicine, explores access to leukemia treatment in Brazil, and more.

Block title